These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 24582719

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA, Pudi KK, Zvarich MT, Sanford L, Siederer SK, Crim C.
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [Abstract] [Full Text] [Related]

  • 23. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.
    Ofir D, Laveneziana P, Webb KA, Lam YM, O'Donnell DE.
    Am J Respir Crit Care Med; 2008 Mar 15; 177(6):622-9. PubMed ID: 18006885
    [Abstract] [Full Text] [Related]

  • 24. Safety of neurokinin-1 receptor antagonists.
    Muñoz M, Coveñas R.
    Expert Opin Drug Saf; 2013 Sep 15; 12(5):673-85. PubMed ID: 23706125
    [Abstract] [Full Text] [Related]

  • 25. The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs.
    Munoz M, Covenas R, Esteban F, Redondo M.
    J Biosci; 2015 Jun 15; 40(2):441-63. PubMed ID: 25963269
    [Abstract] [Full Text] [Related]

  • 26. Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease.
    Mahler DA.
    Proc Am Thorac Soc; 2006 May 15; 3(3):234-8. PubMed ID: 16636091
    [Abstract] [Full Text] [Related]

  • 27. Association of Descriptors of Breathlessness With Diagnosis and Self-Reported Severity of Breathlessness in Patients With Advanced Chronic Obstructive Pulmonary Disease or Cancer.
    Chowienczyk S, Javadzadeh S, Booth S, Farquhar M.
    J Pain Symptom Manage; 2016 Aug 15; 52(2):259-64. PubMed ID: 27233139
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Bu-Fei Yi-Shen granule combined with acupoint sticking therapy in patients with stable chronic obstructive pulmonary disease: a randomized, double-blind, double-dummy, active-controlled, 4-center study.
    Li JS, Li SY, Yu XQ, Xie Y, Wang MH, Li ZG, Zhang NZ, Shao SJ, Zhang YJ, Zhu L, Guo LX, Bai YP, Wang YF.
    J Ethnopharmacol; 2012 Jun 01; 141(2):584-91. PubMed ID: 21911051
    [Abstract] [Full Text] [Related]

  • 32. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
    Belman MJ, Botnick WC, Shin JW.
    Am J Respir Crit Care Med; 1996 Mar 01; 153(3):967-75. PubMed ID: 8630581
    [Abstract] [Full Text] [Related]

  • 33. Outcome measurement of refractory breathlessness: endpoints and important differences.
    Ekström M, Currow DC, Johnson MJ.
    Curr Opin Support Palliat Care; 2015 Sep 01; 9(3):238-43. PubMed ID: 26203849
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug.
    Muñoz M, Rosso M.
    Invest New Drugs; 2010 Apr 01; 28(2):187-93. PubMed ID: 19148578
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Results of a pilot investigation into a complex intervention for breathlessness in advanced chronic obstructive pulmonary disease (COPD): brief report.
    Farquhar M, Higginson IJ, Fagan P, Booth S.
    Palliat Support Care; 2010 Jun 01; 8(2):143-9. PubMed ID: 20307365
    [Abstract] [Full Text] [Related]

  • 40. Aprepitant (EMEND): the role of substance P in nausea and vomiting.
    Prommer E.
    J Pain Palliat Care Pharmacother; 2005 Jun 01; 19(3):31-9. PubMed ID: 16219609
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.